CDK4 and neutropenia: However, grade 3+ hematological toxicity was mostly represented by neutropenia, with a higher incidence observed with Palbociclib and Ribociclib compared with Abemaciclib, because Abemaciclib shows greater selectivity to CDK4 (29).